No photo available yet
Agilent Technologies Rapidly induce and express phosphorylated proteins
Agilent Technologies Rapidly induce and express phosphorylated proteins — Protein expression.
The Agilent Phosphoprotein Generation workflow is a molecular-biology process kit, not an instrument: it combines expression vectors, competent cells and mutagenesis reagents to rapidly induce and express phosphorylated proteins. It is distinguished inside the Agilent synthetic-biology portfolio by targeting phosphorylated protein output rather than cloning speed or viral delivery. It serves upstream protein-production steps feeding structural, signalling or assay development work.
Full specifications
| Aav Gene Delivery Efficiency | 90 % |
| Aav Maximum Insert Size | 3 kb |
| Adeasy Maximum Insert Size | 7.5 kb |
| Adeasy Xl Gene Delivery Efficiency | 90 % |
| Quikchange Ht Mutational Region | 50 AA |
| Quikchange Lightning Multi Thermocycling Time Reduction | 75 % |
| Surevector Assembly Reaction Time | 20 min |
| Surevector Time To New Vector | 1 day |
| QuikChange HT oligos per reaction mfr | 950 oligos |
| SURE 2 Supercompetent cells transformation efficiency mfr | 1 cfu/μg |
| SURE Electroporation Competent cells transformation efficiency mfr | 1 cfu/μg |
| SURE Competent cells transformation efficiency mfr | 5 cfu/μg |
| ABLE K Competent cells transformation efficiency mfr | 5 cfu/μg |
| TG1 Competent cells transformation efficiency mfr | 1 cfu/μg |
| XL10-Gold Ultracompetent cells transformation efficiency mfr | 5 cfu/μg |
| ElectroTen-Blue Electroporation Competent cells transformation efficiency mfr | 3 cfu/μg |
| SoloPack Gold Supercompetent cells transformation efficiency mfr | 1 cfu/μg |
| SoloPack Gold Competent cells transformation efficiency mfr | 1 cfu/μg |
| XL1-Blue Electroporation Competent cells transformation efficiency mfr | 10 cfu/μg |
| XL2-Blue Ultracompetent cells transformation efficiency mfr | 5 cfu/μg |
| BL21-CodonPlus (DE3)RIPL Competent cells transformation efficiency mfr | 1 cfu/μg |
| Transformation efficiency mfr | 1 cfu/μg |
| Mammalian mfr | 6 |
| QuikChange HT1 mfr | 20 protein |
| GeneMorph II mfr | Mutagenic polymerase for balanced random mutagen |
| StrataClone PCR Cloning kit mfr | 240205 |
| StrataClone Blunt Cloning kit mfr | 240207 |
| StrataClone Ultra Blunt Cloning kit mfr | 240218 |
| Gigapack III XL Packaging Extract mfr | 200209 |
| SureGuide Cas9 Programmable Nuclease, 100 rxn mfr | 5190 |
| SureGuide Cas9 Programmable Nuclease kit, 20 rxn mfr | 5190 |
| SureGuide Cas9 Programmable Nuclease kit, 100 rxn mfr | 5190 |
| pAAV-hrGFP vector mfr | 20 μg |
| pAAV-IRES-hrGFP vector mfr | 20 μg |
| AAV-293 cells mfr | 1 cells |
| AAV-HT1080 cells mfr | 1 cells |
| BJ5183-AD1 electrophoration-competent cells mfr | 5 μL |
| BJ5183 electroporation-competent cells mfr | 5 μL |
| pAdEasy-1 vector mfr | 2.5 μg |
| pShuttle vector mfr | 20 μg |
| pShuttle-CMV vector mfr | 20 μg |
| pShuttle-CMV-IacZ control vector mfr | 10 μg |
| pShuttle-IRES-hrGFP-1 mfr | 20 μg |
| pShuttle-IRES-hrGFP-2 mfr | 20 μg |
| Long-Term Gene Expression mfr | AAV Helper-Free system system |
| Transient, High-Level Gene Expression mfr | AdEasy Adenoviral system system |
| maximum fragments per assembly mfr | seven fragments fragments |
| design-to-transformation time mfr | 30 minutes |
| mutation efficiency mfr | 80 |
| StrataClone cloning time mfr | 5 minutes |
| InterPlay N-Terminal Mammalian TAP system kit mfr | 240103 |
| InterPlay C-Terminal Mammalian TAP system kit mfr | 240104 |
| InterPlay N-Terminal Mammalian TAP vectors, 3 x 20 μg mfr | 240214 |
| InterPlay C-Terminal Mammalian TAP vectors, 3 x 20 μg mfr | 240216 |
| InterPlay Adenoviral N-Terminal TAP mfr | 240213 |
| InterPlay Adenoviral C-Terminal TAP mfr | 240215 |
| Standard Transfection Gene Delivery Efficiency | 20 % |
Description
Construction and positioning
- The Phosphoprotein Generation offering is a reagent/workflow bundle assembled from Agilent's expression, competent-cell and mutagenesis product families; it is not a standalone hardware unit and carries no electrical, mechanical or environmental ratings.
- No sibling models are defined for this series, so positioning is against the broader Agilent portfolio: SureVector cloning kits (20 min assembly, 1 day to new vector), QuikChange mutagenesis (Lightning Multi cuts thermocycling time by 75 %; HT covers 50 AA mutational regions with 950 oligos per reaction), and viral systems (AAV max insert 3 kb; AdEasy max insert 7.5 kb).
- Gene-delivery efficiencies quoted in the portfolio are 90 % for AAV and AdEasy XL and 20 % for standard transfection; these belong to those named systems, not to the phosphoprotein workflow itself.
Behaviour and process role
- The workflow's purpose is to induce and express phosphorylated proteins rapidly; the supplied facts give no induction temperature, time course, yield or phosphorylation-efficiency figures, so no process window can be stated.
- Competent-cell transformation efficiencies in the portfolio range from 1 to 10 cfu/µg depending on strain and format (e.g. XL1-Blue electroporation 10 cfu/µg; SURE, TG1, SoloPack Gold 1 cfu/µg), which sets the practical sensitivity floor when choosing a host for the expression construct.
- Time-to-new-vector for the cloning kits is stated as both 1 day (SureVector) and three to four weeks (extra spec); these refer to different products and must not be applied to this workflow.
Installation, control and operation
- The attached brochure digests contain no sections or actionable engineering facts for this workflow; no installation, connection, control or operating instructions can be derived from them.
- Operation is bench-scale molecular biology: vector construction, transformation into a competent host, and induced expression. Consumables and hosts are selected from the Agilent competent-cell portfolio listed in the brochure.
Integration & Operating Notes
Portfolio competent cells differ by up to tenfold in transformation efficiency (1 to 10 cfu/µg depending on strain and chemical vs electroporation format). Select the host against the required construct size and selection markers before committing the expression run, because a low-efficiency host limits how much template can be recovered.
The verified facts contain no voltage, power, temperature, pressure or flow specifications for the phosphoprotein workflow. Integration planning should treat it as a reagent-and-protocol package; any equipment used alongside it (thermocycler, incubator, electroporator) must be specified from its own documentation.
Because no certificates or shelf-life data are supplied in the verified facts, record lot numbers and storage conditions for each kit component at receipt. This preserves traceability for phosphorylation results and allows replacement of a single failing component without repeating the whole workflow.
Selection & Integration Q&A
Choose this workflow when the goal is induced expression of phosphorylated protein. Pick SureVector when the bottleneck is vector assembly (20 min reaction, 1 day to new vector) and QuikChange when the task is site-directed mutation (Lightning Multi cuts thermocycling time 75 %; HT covers 50 AA regions).
The brochure lists strains from 1 to 10 cfu/µg: XL1-Blue electroporation 10, XL10-Gold and XL2-Blue 5, SURE, TG1, SoloPack Gold and BL21-CodonPlus (DE3)RIPL 1. Match the host to construct size and markers; higher-efficiency strains ease recovery of large or low-yield constructs.
None are documented. The attached brochure digests contain no sections or actionable engineering facts, and the verified specs carry no temperature, humidity or duty-cycle values. Treat it as bench molecular biology and take environmental limits from the thermocycler, incubator or electroporator you pair it with.
No service intervals or included-accessory list is given in the verified facts. Competent cells, vectors and mutagenesis reagents are separate catalogue items (e.g. G7514A SureVector, 210514 QuikChange Lightning Multi, 240071 AAV Helper-Free). Confirm kit contents and any AMP Tabs or IPTG against the order.